Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (2)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
STADA - Caring for People's Health
A message from Peter Goldschmidt, CEO
I am immensely proud of the group’s outstanding performance in 2023.
Against a backdrop of geopolitical conflicts and economic challenges, we were able to maintain our double-digit growth trend based on our unique culture.
This performance fully in line with our corporate vision, shows the benefit of having a consistent strategy that has delivered sustained strong growth over several years.
Above all, our ability to maintain double-digit sales and profit growth from continuing operations is down to one thing: the extraordinary dedication and expertise of our around 11,700 employees worldwide. Put simply, our unique culture drove our outstanding performance in 2023.
"Our success is based on our culture and our purpose of
Caring for People’s Health as a Trusted Partner."
STADA has outperformed its competitors
STADA’s ability to maintain double-digit growth on the top and bottom line is a testament to the effectiveness of our consistent strategy, vision, values and purpose.
Boris Döbler
Culture drives Performance
Worldwide (on average - based on FTE) + 8%
Women in leadership positions
Employee satisfaction score
STADA is a testimony of Culture drives Performance. It is our ambition to continue building a sustainable environment in which our people grow and excel, today and tomorrow. I truly believe that a healthy, self-empowered organization translates to a strong growth culture that ultimately drives performance!
Simone Berger
STADA is proud to be among the most sustainable pharmaceutical companies globally.
This independent assessment reflects the group’s commitment to working as a trusted partner with customer, regulator and capital market stakeholders to ensure that STADA has sound foundations for sustained success.
Consistent with its own areas of business, company purpose, and values, STADA supports the implementation of the following SDGs:
STADA has become the market leader in Consumer Healthcare in Germany. The company has also secured market leadership in Serbia and ranks second in Belgium. Sales in France, Italy and Spain also grew strongly during the past financial year. This makes STADA the fourth-largest Consumer Healthcare company in Europe.
STADA CHC has strongly outperformed the market. By broadly activating our unique portfolio of local brand heroes across categories and countries, we have delivered exceptional growth of 17%. Testimony that our corporate culture - the agile and entrepreneurial thinking and actions of our employees – is the basis for our continuing success.
Volker Sydow
Based on a thorough understanding of people’s needs and desires, we develop appealing innovations that extend the value of our strong local hero brands.
Yann Brun
Generics: Enabling affordable access
Generic medicines are crucial in ensuring that patients have access to high-quality medicines at affordable prices, and are indispensable for the financial viability of healthcare systems. Therefore, European legislators must ensure that their decisions preserve and enhance patient access to these essential medicines.
Stephan Eder
Data from the STADA Health Report show that many Eastern Europeans see room for improvement in their national healthcare systems. The use of generics can simply ensure access to high-quality medicines at affordable prices.
Christos Gallis
Specialty: serving specific patient needs
Such therapies include biological medicines that usually require cold-chain storage and administration via injection or infusion; device-aided therapies such as on body pumps, pre-filled syringes or autoinjector pens; and ‘orphan’ medicines authorized for treating rare diseases that require specialist treatment.
Across therapeutic categories including nephrology, neurology, immunology, oncology and ophthalmology, STADA is bringing innovative Specialty products that meet the specific needs of patients and healthcare professionals.
Bryan Kim
One STADA story – writing the next chapter
We are convinced that wellconnected and committed employees strengthen the growth culture of our company.
Frank Staud
STADA Production sites – keep supplying medicines
United Kingdom
Huddersfield
Preston
Austria
Tulln
Germany
Pfaffenhofen
Uetersen
Vietnam
Tuy Hoa (PME1 and PME2)
Bosnia and Herzegovina
Banja Luka
China
Miyun
Czech Republic
Trinec
Montenegro
Podgorica
Sabac
Vrsac/Dubovac
Ukraine
Bila Tserkva
Through our network of 17 production sites worldwide, supported by partnerships with thousands of trusted suppliers, STADA makes a major contribution to providing patients access to high-quality, medicines.
Miguel Pagan Fernandez
Ensuring we protect the environment, make a positive impact on society and comply fully with all relevant governance regulations aligns perfectly with STADA’s Purpose of Caring for People’s Healthas a Trusted Partner.
Christoph Dengler
